| AERD | Aspirin-Exacerbated Respiratory Syndrome |
| ACOS | Asthma-COPD Overlap Syndrome |
| AG | Andrographolide |
| ATP | Adenosine Triphosphate |
| BALB/C | Bagg and Albino Mice (White Lab Mice) |
| COPD | Chronic Obstructive Pulmonary Disorder |
| DMPC | Dimyristoyl-sn-glycero-3-phosphocholine |
| DPI | Dry Powder Inhaler |
| FACET | Formoterol and Corticosteroids Establishing Therapy |
| FEV1 | Forced Expiratory Volume in the 1st Second |
| GERD | GastroEsophageal Reflux Disease |
| GOAL | Gaining Optimal Asthma controL |
| HSPC | Hydrogenated Soybean Phosphatidylcholine |
| hUCMSCs | Human Umbilical Cord MSCs |
| ICS | Inhaled Corticosteroids |
| IL | Interleukin |
| ILC2s | Group 2 Innate Lymphoid Cells |
| LABA/LAMA | Long-Acting Beta/Muscarinic Agonist |
| LRA | Leukotriene Receptor Antagonist |
| miR-1470 | Micro RNA 1470 |
| MSC | Mesenchymal Stem Cell |
| MSC-Exo | Exosomes Derived from Mesenchymal Stem Cells |
| PLGA | Polylactide-co-glycolide |
| pMDI | Pressurized Metered Dose Inhaler |
| poly(I:C) | Polyinosin-polycytidylic acid |
| sEV | MSC-small Extracellular Vesicles |
| SPIO | Superparamagnetic Nanoparticles of Iron Oxides |